Heptane

Heptane

SCHEMBL7969065

CCC(CC)C(=O)O.CCCCCCC

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.77
MAPK1 P28482 1/20 0.77
GRIK1 P39086 2/20 0.59
GRIK2 Q13002 2/20 0.59
SLC1A2 P43004 2/20 0.55
SLC1A1 P43005 2/20 0.55
GPR84 Q9NQS5 6/20 0.54
FFAR1 O14842 2/20 0.54
CA1 P00915 1/20 0.54
TDP1 Q9NUW8 3/20 0.52
CHRM1 P11229 1/20 0.52
AKR1A1 P14550 1/20 0.52
CHRM3 P20309 1/20 0.52
HTR2A P28223 1/20 0.52
HTR2C P28335 1/20 0.52
ADRA1A P35348 1/20 0.52
HRH1 P35367 1/20 0.52
DRD3 P35462 1/20 0.52
SLC6A3 Q01959 1/20 0.52
HDAC1 Q13547 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexane SCHEMBL3187009 0.97 CA2 (0.81) CA2MAPK1GRIK1GRIK2SLC1A2
Hexane SCHEMBL4788148 0.93 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
Hexane SCHEMBL18237384 0.93 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL687840 0.93 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL10788879 0.93 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL2492860 0.93 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL3003696 0.93 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL17329112 0.93 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL1704587 0.93 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL249553 0.93 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 US disclosed
CN-1204323-A Use of tricyclic 1,4-dihydro-1,4-dioxo-1 H-naphthalene derivatives, resulting novel compounds and therapeutical use thereof INNOTHERA LAB SA (FR) 1999-01-06 CN disclosed